HF
CDIOW icon

HRT Financial’s Cardio Diagnostics Holdings Inc Warrant CDIOW Stock Holding History

HRT Financial’s Portfolio CDIOW Stock Details CDIOW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-36,000
Closed -$1K – 2490
2024
Q2 		$1K Sell
36,000
-936
-3% -$57 ﹤0.01% 2103
2024
Q1 		$4K Buy
36,936
+2,025
+6% +$304 ﹤0.01% 2116
2023
Q4 		$6K Sell
34,911
-1,089
-3% -$108 ﹤0.01% 2116
2023
Q3 		$1K Hold
36,000
– – ﹤0.01% 2270
2023
Q2 		$6K Sell
36,000
-291
-0.8% -$53 ﹤0.01% 2213
2023
Q1 		$10K Buy
36,291
+91
+0.3% +$21 ﹤0.01% 2246
2022
Q4 		$1K Buy
36,200
+200
+0.6% +$24 ﹤0.01% 2370
2022
Q3 		$4K Hold
36,000
– – ﹤0.01% 2608
2022
Q2 		$5K Hold
36,000
– – ﹤0.01% 2738
2022
Q1 		$7K Buy
+36,000
New +$8.55K ﹤0.01% 2929

Other funds holding CDIOW

BFM
Boothbay Fund Management New York $7.71B AUM 106.29% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
SCM
Saba Capital Management New York $3.62B AUM 12.96% 1-Year Est. Return
Walleye Trading
Walleye Trading New York $87.6B AUM 68.17% 1-Year Est. Return
CS
Clear Street New York $24.6B AUM 56.25% 1-Year Est. Return
CCM
Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
ASM
ATW SPAC Management New York $79.2M AUM 10.61% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

HRT Financial's CDIOW Position: Q3 2024 in Review

HRT Financial sold out of Cardio Diagnostics Holdings Inc Warrant (CDIOW) in Q3 2024, closing a stake of 36,000 shares — an estimated $1K sold.

HRT Financial first reported a position in CDIOW in Q1 2022 and held it in 10 quarters. The position peaked at $10K in Q1 2023. 10 funds tracked by Wall St. Rank hold CDIOW as of Q3 2024.

  • HRT Financial reported no remaining Cardio Diagnostics Holdings Inc Warrant position as of Q3 2024 after selling out during the quarter.
  • HRT Financial sold 36,000 Cardio Diagnostics Holdings Inc Warrant shares in Q3 2024, an estimated $1K.
  • HRT Financial first reported a position in Cardio Diagnostics Holdings Inc Warrant in Q1 2022 and held it in 10 quarters.
  • HRT Financial's Cardio Diagnostics Holdings Inc Warrant position peaked at $10K in Q1 2023.
  • 10 funds tracked by Wall St. Rank held Cardio Diagnostics Holdings Inc Warrant as of Q3 2024.

Based on HRT Financial's 13F filing for Q3 2024, filed 12 Nov 2024.